Skip to main content

Day: July 31, 2025

Exponent Declares Regular Quarterly Dividend for Q3 2025

MENLO PARK, Calif., July 31, 2025 (GLOBE NEWSWIRE) — Exponent, Inc. (Nasdaq: EXPO) today announced that its Board of Directors has declared a quarterly cash dividend of $0.30 per share of common stock to be paid on September 19, 2025, to all common stockholders of record as of September 5, 2025. Exponent has paid, and expects to continue to pay, quarterly dividends each year in March, June, September, and December. Future declarations of quarterly dividends and the establishment of future record and payment dates are subject to the final determination of Exponent’s Board of Directors. “Exponent’s quarterly dividend reflects our steadfast commitment to returning capital to shareholders,” commented Dr. Catherine Corrigan, President and Chief Executive Officer. “As expectations around safety, health, and the environment continue to...

Continue reading

StoneX Completes Acquisition of R.J. O’Brien, Becoming the Largest Non-Bank FCM in the United States and Enhancing Global Multi-Asset Capabilities

The most significant acquisition in StoneX history unites two of the most well-respected names in the futures industry, combining 200+ years of derivatives expertise NEW YORK, July 31, 2025 (GLOBE NEWSWIRE) — StoneX Group Inc. (NASDAQ: SNEX) (“StoneX” or the “Company”), today announced the successful completion of its previously announced acquisition of R.J. O’Brien (“RJO”), the oldest independent futures brokerage in the United States. This transformative acquisition makes StoneX the largest non-bank Futures Commission Merchant (“FCM”) in the U.S. and positions the company as a market leader in global derivatives. Founded in 1914, RJO supports over 75,000 client accounts and serves the industry’s largest global network of approximately 300 introducing brokers (“IBs”), as well as commercial and institutional clients, and individual...

Continue reading

Vancity reports strong Q2 results, early evidence of transformation to Vancity 2.0

TERRITORIES OF MUSQUEAM, SQUAMISH AND TSLEIL-WAUTUTH NATIONS and VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — Vancity delivered strong financial results at the end of the second quarter that ended on June 30, 2025, highlighting growth across key areas for the credit union. This solid performance reveals wins for a new strategy aimed at growing with impact and delivering exceptional member experience.  Core revenues climbed to $307.5 million by June 30th, representing a 24% increase compared to 2024 and marking continued growth in revenues and profitability in 2025. This includes $157.6 million added in the second quarter. Income before tax and distributions grew to $46.6 million year-to-date, with the second quarter adding $25.1 million. Member deposits increased by $97.8 million — $63.5 million in the second quarter...

Continue reading

Alpine Banks of Colorado announces financial results for second quarter 2025

GLENWOOD SPRINGS, Colo., July 31, 2025 (GLOBE NEWSWIRE) — Alpine Banks of Colorado (OTCQX: ALPIB) (“Alpine” or the “Company”), the holding company for Alpine Bank (the “Bank”), today announced results (unaudited) for the second quarter ended June 30, 2025. The Company reported net income of $17.6 million, or $1.10 per basic Class A common share and basic Class B common share, for second quarter 2025. Highlights in second quarter 2025 include:Basic earnings per Class A and Class B common shares increased 23.1%, or $0.21, during second quarter 2025. Basic earnings per Class A and Class B common shares increased 44.3%, or $0.61, compared to second quarter 2024. Net interest margin for second quarter 2025 was 3.50%, compared to 3.38% in first quarter 2025, and 2.87% in second quarter 2024.“Our second quarter results reflect our...

Continue reading

Lincoln Tech Campuses Named USA Today’s “Top Vocational Schools” for 2025

Melrose Park, IL and South Plainfield, NJ schools recognized for commitment to student success, diversity.Lincoln Tech Is a National Leader in Hands-On Career TrainingStudents train with industry-standard equipment in a supportive learning environment.Lincoln Tech Focuses on Student SuccessLincoln Tech is committed to excellence in hands-on education, career readiness and workforce development.PARSIPPANY, NJ – July 31, 2025, July 31, 2025 (GLOBE NEWSWIRE) — Lincoln Educational Services Corporation (NASDAQ: LINC), a national leader in specialized technical training for nearly 80 years, announced today that two of its campuses have been named “America’s Top Vocational Schools” for 2025 by USA Today. Campuses in Melrose Park, IL and South Plainfield, NJ have been selected based on a number of factors focused on...

Continue reading

In response to the rise in injection attacks, technology company Facephi takes action to strengthen and secure digital identity processes

Facephi, a leading provider and developer in the identity verification sector, reinforces digital identity protection with its new feature, Advanced Injection Defense, designed to stop deepfakes and manipulated images and videosfacephi injection defensefacephi injection defenseBUENOS AIRES, Argentina, July 31, 2025 (GLOBE NEWSWIRE) — In recent months, the country has witnessed how vast amounts of personal data — including sensitive information linked to official documents — have been exposed and begun circulating freely online. Millions of records accessible to virtually anyone. These types of breaches, combined with the growing sophistication of tools capable of generating high-precision fake images and videos, have created a perfect storm for digital identity fraud. In response, Facephi, experts in verified digital...

Continue reading

J-Star Holding Announces Closing of $5.0 Million Initial Public Offering

TAICHUNG CITY, Taiwan, July 31, 2025 (GLOBE NEWSWIRE) — J-Star Holding Co., Ltd. (“J-Star” or the “Company”), a leading provider of innovative carbon fiber and composite solutions across a wide range of applications including personal sports equipment, healthcare products, automobile parts, resin systems, and research and development services, today announced the closing of its previously announced initial public offering of an aggregate 1,250,000 ordinary shares of the Company (the “Offering”) at a price of $4.00 per share (the “Offering Price”). The shares began trading on the Nasdaq Capital Market on July 30, 2025, under the symbol “YMAT.” In addition, the Company has granted Maxim (as defined below) a 45-day option to purchase up to an additional 187,500 share of its ordinary shares at the Offering Price (the “Over-allotment”),...

Continue reading

SeaStar Medical Announces $4.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

DENVER, July 31, 2025 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life, today announced it has entered into a definitive agreement for the issuance and sale of an aggregate of 4,960,544 shares of its common stock (or common stock equivalents in lieu thereof) at a purchase price of $0.887 per share of common stock (or per common stock equivalent in lieu thereof), in a registered direct offering priced at-the-market under Nasdaq rules. In addition, in a concurrent private placement, SeaStar Medical will issue and sell unregistered warrants to purchase up to 4,960,544 shares of common stock. The warrants will have an exercise price of $0.762 per share, will be exercisable...

Continue reading

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes Trial

PolTREG and U.S. Subsidiary Immuthera Secure Positive FDA Opinion, Paving the Way for a Registrational Pre-Symptomatic Type 1 Diabetes TrialFDA agreed that PolTREG’s clinical data in Stage 3 Type 1 Diabetes (T1D) appears sufficient to support the Prospect of Direct benefit in an adaptive Phase 2/3 study of PTG-007 in Stage 1 and Stage 2 Presymptomatic T1D patients. The FDA is receptive to the inclusion of Stage 1 Polish patients in the trial’s statistical analyses FDA may consider the adaptive Phase 2/3 study as registrational, potentially expediting U.S. approval for PTG-007 in presymptomatic Type 1 diabetes. PolTREG and Immuthera will apply for Fast Track, Breakthrough, or Regenerative Medicine Advanced Therapy (RMAT) designation in the IND filing.31 July 2025 – PolTREG S.A. (Warsaw Stock Exchange: PTG), a pioneer in cell therapies...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.